Through using the entire range of quantitative fFN, predictive abilities and in turn clinical utility is not limited to a fixed threshold. High levels of quantitative fFN can be used to improve PPV, while low levels can be used to rule out imminent delivery. In clinical practice, ruling out imminent delivery is far more important; clinicians only withhold treatment for women at very low risk, but will treat most women at moderate risk or higher [1] .
The absence of a power calculation, a small sample of 72 patient and an event rate of only three women who delivered within 7 d of presenting limits the statistical certainty of their findings. Although the authors acknowledge these shortcomings within the discussion, they state that the "PAMG-1 test is a better predictor of spontaneous delivery" and claim that the "PAMG-1 test was statistically superior". Both statements are misleading.
The authors found that both PAMG-1 and fFN (at 10 and 50 ng/mL) have the same sensitivity (67%). Both have poor sensitivityone third of women who go on to have a preterm birth would be falsely reassured. However, the wide confidence interval (67%, CI 9.43-99.6) make these statistics (and all of their statistics) almost meaningless; this implies in women with actual preterm birth, over 90% could have a negative test, or the test is near perfect. Bigger studies are needed.
By combining quantitative fFN, cervical length and medical history, we have been able to improve prediction statistics to clinically useful levels in appropriately powered studies [2, 3] . These are currently being trialed in clinical practice.
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